Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ZION heads into its Monday (October 19) earnings release with analysts broadly cautious and short sellers adding exposure at the fastest pace in months.
The most telling pre-earnings signal is the direction of analyst target cuts. Across the past three weeks, the target-price revisions have been almost uniformly lower. JP Morgan trimmed to $65, Evercore ISI cut to $64, Truist pulled back to $67, TD Cowen to $69, and Piper Sandler to $68, all while maintaining their existing ratings. The lone bright spot arrived on October 15, when Baird upgraded to Outperform, though kept its target unchanged at $75. The consensus remains a hold across 19 analysts, with eight buys but no price-target mean that would credibly justify a sharp re-rating from here given the current $63.37 close. The direction of travel from the analyst community is clear: expectations have been walked lower heading into the print.
The bull-bear debate centres on whether the bank's credit quality and capital strength can offset pressure on core revenue. Bulls point to provision expense of just $3 million against a $21 million forecast, net charge-offs of 6 basis points, and five consecutive quarters of reserve releases. Loan balances rose 1.2% quarter-over-quarter to $61.86 billion, and CET1 reached 11.6%. Bears counter that the Q2 headline number was distorted by $215 million of Visa gains and a $37 million investment valuation benefit. Strip those out, and core pre-provision revenue still missed. Net interest margin was flat at 3.27%, period-end deposits fell to $76.61 billion, and non-interest-bearing balances declined to $26.23 billion, a sign of funding mix pressure that the Street is watching closely.
Short interest tells a more pointed story than the borrow market might imply. Bears have added roughly 38% to their short position over the past month, lifting it to 4.4% of the free float, a meaningful build for a regional bank name. The weekly pace accelerated too, up 9% in the last five sessions to around 6.5 million shares short. That said, borrow conditions impose no constraint on this positioning: availability is extremely loose, with shares available to borrow running at more than 80 times the existing short position, and the cost to borrow has fallen 26% over the past week to just 0.36%. This is a conviction-driven short increase, not a mechanical one driven by scarce supply. Options positioning reinforces the cautious mood. The put/call ratio of 1.51 is essentially in line with its elevated 20-day average of 1.51, making it the structural backdrop rather than a fresh spike, but it remains near the upper half of the past year's range and well above the 52-week low of 0.23.
The stock has fallen 6.8% over the past month, though it has stabilised in recent sessions, adding 1.4% over the past week and 0.6% on Thursday alone. Peers moved in a similar direction Friday, with KEY, RF, CFG, and FITB all posting modest daily gains while showing mixed weekly performance, suggesting no sector-wide catalyst drove ZION's recent recovery. The last two earnings prints both produced negative reactions: a 4.5% fall on the day and 5.2% over five days after the July report, and a 2.1% drop on the day in May.
Monday's print will test whether the bank's credit-quality story is durable enough to stand on its own once the one-off revenue boosts from Q2 are absent from the comparison.
See the live data behind this article on ORTEX.
Open ZION on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
